3-4-diaminocyclobut-3-ene-1-2-dione and Cell-Transformation--Neoplastic

3-4-diaminocyclobut-3-ene-1-2-dione has been researched along with Cell-Transformation--Neoplastic* in 1 studies

Other Studies

1 other study(ies) available for 3-4-diaminocyclobut-3-ene-1-2-dione and Cell-Transformation--Neoplastic

ArticleYear
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer.
    Journal of medicinal chemistry, 2020, 09-10, Volume: 63, Issue:17

    Prostate-specific membrane antigen (PSMA) is a carboxypeptidase that is overexpressed in prostate cancer and is an excellent candidate for targeted diagnostic imaging and therapy. Lysine-ureido-glutamate inhibitors of PSMA radiolabeled with positron-emitting radionuclides can be used for diagnostic imaging with positron emission tomography (PET). A squaramide ester derivative of desferrioxamine B (H

    Topics: Animals; Antigens, Surface; Cell Line, Tumor; Cell Transformation, Neoplastic; Deferoxamine; Enzyme Inhibitors; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Isotope Labeling; Male; Mice; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Quinine; Radioisotopes; Tissue Distribution; Zirconium

2020